...

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Secures FDA Type C Meeting to Advance Parkinson’s Disease Dementia Program

Today 10:50 EST

Via Investor Brand Network

Ocumension Therapeutics Highlights Global Myopia Burden and Regulatory Progress in Low-Dose Atropine Therapies

Today 10:47 EST

Via AB Newswire

How Does Tesla Make Money? ↗

Today 9:53 EST

Via The Motley Fool

Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

Today 8:00 EST

Via Newsfile

Vertex Pharmaceuticals Stock: Analyst Estimates & Ratings

Today 7:54 EST

Via Barchart.com

StoryBoom Partners with Filmmaker James Dalessandro to Empower Future Storytellers

Today 7:45 EST

Via Binary News Network

Honda Recalls Over 256,000 Accord Hybrid Vehicles Over Software Issue ↗

Today 6:01 EST

Via Benzinga

Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes ↗

November 17, 2025

Via Stocktwits

3 Reasons We’re Fans of DexCom (DXCM)

November 17, 2025

Via StockStory

Congress to Convene Critical Hearing on AI Chatbots: Balancing Innovation with Public Safety

November 17, 2025

Via TokenRing AI

Beyond Aesthetics: Medical AI Prioritizes Reliability and Accuracy for Clinical Trust

November 17, 2025

Via TokenRing AI

'My Theory ... Was That Someday a Nun Would Go Bad' – Buffett Recalls Fingerprinting Nuns While Recovering From an Appendectomy ↗

November 17, 2025

Via Benzinga

Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)

November 17, 2025

Via PRLog

Three Revenue-Generating Facilities in Florida Plus Six More by Year-End in Expanding $750 Million Market Suicidal Depression Market: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

November 17, 2025

Via Get News

Medcrypt Achieves 100% FDA Submission Approval Rate and Launches Security Intelligence to Help Mature Medical Device Cybersecurity Program

November 17, 2025

Via PRUnderground

Why Did TNXP Stock Jump 10% Today? ↗

November 17, 2025

Via Stocktwits

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

November 17, 2025

Via NewMediaWire

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

November 17, 2025

Via TheNewswire.com

Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application ↗

November 17, 2025

Via Benzinga

Omeros (OMER) Q3 2025 Earnings Call Transcript ↗

November 17, 2025

Via The Motley Fool

BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study

November 17, 2025

Via Investor Brand Network

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs

November 17, 2025

Via Investor Brand Network

Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK

November 17, 2025

Via TheNewswire.com

Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK

November 17, 2025

Via NewMediaWire

aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR

November 17, 2025

Via NewMediaWire

aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR

November 17, 2025

Via TheNewswire.com

OS Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update

November 17, 2025

Via Newsfile

Is Robinhood Stock a Buy Now? ↗

November 17, 2025

Via The Motley Fool

From Immigrant to Industry Leader: How Julia Biro Built WeDoSkin into Canada’s Fastest-Growing Skincare Retailer

November 17, 2025

Via Press Release Distribution Service

Sarepta Stock Slides Premarket After New FDA Warning Shrinks Market For Its $3.2M DMD Gene Therapy ↗

November 17, 2025

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.